Dorothy matriculated at Harvard University in the Health Policy Ph.D. Program in 2009. Her current research involves analyses of large administrative claims data to evaluate the value of treatment interventions in breast and lung cancer and cost-effectiveness analysis of predictive molecular marker screening in lung cancer using a simulation model. Prior to joining the doctoral program, she worked at the Center for Outcomes and Policy Research where she undertook a variety of projects, including piggyback economic analyses alongside clinical trials, guideline concordance and quality of care evaluations, and analyses of patient-reported outcomes. Dorothy worked as a clinical pharmacist prior to 2000. She received her B.Sc. degree in pharmacy and M.Sc. from the University of Toronto.